$DORM
Dorman Products, Inc.

2021 Q3 Form 10-Q Financial Statement

#000156459021051711 Filed on October 25, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q4 2020 Q3
Revenue $348.4M $301.2M $300.6M
YoY Change 15.9% 25.73% 18.45%
Cost Of Revenue $231.6M $189.8M $192.8M
YoY Change 20.11% 17.67% 15.54%
Gross Profit $116.9M $111.4M $107.8M
YoY Change 8.4% 42.27% 24.02%
Gross Profit Margin 33.54% 36.99% 35.86%
Selling, General & Admin $72.66M $65.50M $63.00M
YoY Change 15.34% 16.34% 5.07%
% of Gross Profit 62.18% 58.8% 58.44%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.081M $9.800M $7.500M
YoY Change 7.75% 100.0% 8.7%
% of Gross Profit 6.92% 8.8% 6.96%
Operating Expenses $72.66M $65.50M $63.00M
YoY Change 15.34% 16.13% 5.07%
Operating Profit $44.19M $45.90M $44.80M
YoY Change -1.36% 109.59% 66.15%
Interest Expense -$733.0K
YoY Change
% of Operating Profit -1.66%
Other Income/Expense, Net $95.00K $0.00 $0.00
YoY Change -100.0% -100.0%
Pretax Income $43.55M $46.00M $44.76M
YoY Change -2.69% 111.01% 65.79%
Income Tax $10.45M $10.00M $10.50M
% Of Pretax Income 23.99% 21.74% 23.45%
Net Earnings $33.10M $36.00M $34.26M
YoY Change -3.37% 105.15% 60.78%
Net Earnings / Revenue 9.5% 11.95% 11.4%
Basic Earnings Per Share $1.04 $1.06
Diluted Earnings Per Share $1.04 $1.115M $1.06
COMMON SHARES
Basic Shares Outstanding 31.69M 32.28M
Diluted Shares Outstanding 31.84M 32.37M

Balance Sheet

Concept 2021 Q3 2020 Q4 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $57.26M $155.6M $170.5M
YoY Change -66.41% 127.49% 214.58%
Cash & Equivalents $57.26M $155.6M $170.5M
Short-Term Investments
Other Short-Term Assets $17.30M $7.800M $11.80M
YoY Change 46.58% -42.65% -27.16%
Inventory $475.5M $298.7M $283.3M
Prepaid Expenses
Receivables $463.1M $460.9M $405.3M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.013B $922.9M $870.9M
YoY Change 16.33% 22.31% 20.14%
LONG-TERM ASSETS
Property, Plant & Equipment $116.3M $91.01M $130.1M
YoY Change -10.6% -10.63% -5.31%
Goodwill $200.0M $91.08M $91.15M
YoY Change 119.45% 22.32% 22.42%
Intangibles $182.8M $25.21M
YoY Change 18.31%
Long-Term Investments $8.500M
YoY Change -55.96%
Other Assets $45.85M $38.98M $40.60M
YoY Change 12.94% -25.53% -22.02%
Total Long-Term Assets $602.7M $297.7M $287.9M
YoY Change 109.35% 3.93% -1.38%
TOTAL ASSETS
Total Short-Term Assets $1.013B $922.9M $870.9M
Total Long-Term Assets $602.7M $297.7M $287.9M
Total Assets $1.616B $1.221B $1.159B
YoY Change 39.44% 17.25% 13.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $149.9M $117.9M $112.8M
YoY Change 32.91% 30.34% 39.58%
Accrued Expenses $223.5M $204.8M $166.6M
YoY Change 34.14% 1324.2% 1041.33%
Deferred Revenue
YoY Change
Short-Term Debt $249.4M $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $622.8M $322.6M $279.4M
YoY Change 122.89% 46.32% 42.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.706M $3.555M $9.629M
YoY Change -51.13% -73.26% -25.26%
Total Long-Term Liabilities $4.706M $3.555M $9.629M
YoY Change -51.13% -73.26% -25.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $622.8M $322.6M $279.4M
Total Long-Term Liabilities $4.706M $3.555M $9.629M
Total Liabilities $627.5M $326.2M $327.5M
YoY Change 91.59% 39.52% 57.12%
SHAREHOLDERS EQUITY
Retained Earnings $830.9M $789.2M $774.1M
YoY Change 7.33% 9.51% 7.56%
Common Stock $73.64M $64.41M $57.22M
YoY Change 28.71% 21.68% 8.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $904.5M $853.6M $831.4M
YoY Change
Total Liabilities & Shareholders Equity $1.616B $1.221B $1.159B
YoY Change 39.44% 17.25% 13.97%

Cashflow Statement

Concept 2021 Q3 2020 Q4 2020 Q3
OPERATING ACTIVITIES
Net Income $33.10M $36.00M $34.26M
YoY Change -3.37% 105.15% 60.78%
Depreciation, Depletion And Amortization $8.081M $9.800M $7.500M
YoY Change 7.75% 100.0% 8.7%
Cash From Operating Activities $38.51M $6.300M -$73.70M
YoY Change -152.26% -82.3% -417.67%
INVESTING ACTIVITIES
Capital Expenditures -$5.121M -$3.400M -$5.000M
YoY Change 2.42% -30.61% -32.43%
Acquisitions
YoY Change
Other Investing Activities -$345.5M -$500.0K $0.00
YoY Change
Cash From Investing Activities -$350.6M -$3.900M -$4.900M
YoY Change 7055.18% -20.41% -33.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 213.8M -17.30M -110.5M
YoY Change -293.51% 4.22% 110400.0%
NET CHANGE
Cash From Operating Activities 38.51M 6.300M -73.70M
Cash From Investing Activities -350.6M -3.900M -4.900M
Cash From Financing Activities 213.8M -17.30M -110.5M
Net Change In Cash -98.26M -14.90M -189.1M
YoY Change -48.04% -205.67% -1304.46%
FREE CASH FLOW
Cash From Operating Activities $38.51M $6.300M -$73.70M
Capital Expenditures -$5.121M -$3.400M -$5.000M
Free Cash Flow $43.63M $9.700M -$68.70M
YoY Change -163.52% -76.05% -324.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M18D
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32371000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y7M6D
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31895000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32317000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32039000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32394000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57263000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155576000
CY2021Q3 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
1248000
CY2020Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
1260000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
463113000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
460878000
CY2021Q3 us-gaap Inventory Net
InventoryNet
475462000
CY2020Q4 us-gaap Inventory Net
InventoryNet
298719000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17297000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7758000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
1013135000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
922931000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
116309000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
91009000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
57698000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
39002000
CY2021Q3 us-gaap Goodwill
Goodwill
200026000
CY2020Q4 us-gaap Goodwill
Goodwill
91080000
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
182827000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
25207000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12450000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
45853000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38982000
CY2021Q3 us-gaap Assets
Assets
1615848000
CY2020Q4 us-gaap Assets
Assets
1220661000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
149925000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
117878000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21081000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
19711000
CY2021Q3 dorm Accrued Customer Rebates And Returns
AccruedCustomerRebatesAndReturns
180594000
CY2020Q4 dorm Accrued Customer Rebates And Returns
AccruedCustomerRebatesAndReturns
155751000
CY2021Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
249360000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
21800000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
29305000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
622760000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
322645000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
52530000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37083000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4706000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3555000
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
31328000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3819000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31658703
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31658703
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32168740
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32168740
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
73325000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
64085000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
830882000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
789152000
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
317000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
322000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
904524000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1615848000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1220661000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
892985000
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
173000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1721000
CY2021Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
23364000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1248000
CY2020Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
11448000
CY2020Q3 dorm Stock Issued During Period Value Restricted Stock Award Cancelled Net Of Issuances
StockIssuedDuringPeriodValueRestrictedStockAwardCancelledNetOfIssuances
1000
dorm Stock Issued During Period Value Restricted Stock Award Cancelled Net Of Issuances
StockIssuedDuringPeriodValueRestrictedStockAwardCancelledNetOfIssuances
-504000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-295000
us-gaap Net Income Loss
NetIncomeLoss
70919000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
831365000
us-gaap Profit Loss
ProfitLoss
97452000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
24931000
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
2498000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
61000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-414000
us-gaap Share Based Compensation
ShareBasedCompensation
6212000
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
2418000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
3000000
CY2021Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
371408000
CY2020Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
345525000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
14308000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12061000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26369000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
252360000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
99000000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
99000000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7982000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4215000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
909000
dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
1055000
dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
112000
dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
54272000
dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
17313000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
184855000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17201000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-12000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-98313000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
102149000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
155576000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
68353000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
57263000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
170502000
us-gaap Interest Paid Net
InterestPaidNet
567000
us-gaap Interest Paid Net
InterestPaidNet
680000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
37500000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
19575000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1070238000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
918874000
CY2021Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
37089000
CY2020Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
36085000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
108016000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
62832000
CY2021Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
1.16
CY2020Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
1.11
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
3.37
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
1.94
dorm Maximum Credit Terms Allow To Customers
MaximumCreditTermsAllowToCustomers
P365D
CY2021Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
10467000
CY2021Q3 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
198205000
CY2020Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
136726000
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
257141000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
157484000
CY2021Q3 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
9649000
CY2020Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
4509000
CY2021Q3 us-gaap Inventory Net
InventoryNet
475462000
CY2020Q4 us-gaap Inventory Net
InventoryNet
298719000
CY2019Q4 us-gaap Goodwill
Goodwill
74458000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
108946000
CY2020Q4 us-gaap Goodwill
Goodwill
91080000
CY2020 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
16622000
CY2020Q4 us-gaap Goodwill
Goodwill
91080000
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
194807000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11980000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
182827000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34407000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9200000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
25207000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2900000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2500000
dorm Payment For Contingent Consideration Liability Operating And Financing Activities
PaymentForContingentConsiderationLiabilityOperatingAndFinancingActivities
10400000
us-gaap Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
3600000
dorm Maximum Credit Terms Allow To Customers
MaximumCreditTermsAllowToCustomers
P365D
us-gaap Net Income Loss
NetIncomeLoss
97452000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
348426000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
300620000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
947073000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
791532000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
217735
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
72.77
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
76984
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
106.23
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
36042
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
67.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
45451
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
74.61
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
213226
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
85.42
CY2021Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
300000
CY2020Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
300000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
900000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
800000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
250779
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
70.21
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
58393
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
101.47
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
9457
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
79.02
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
39794
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
66.11
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
259921
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
77.54
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5228021000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
94762
CY2021Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
73.84
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2159758000
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19000
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
141000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
33104000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
34259000
us-gaap Net Income Loss
NetIncomeLoss
70919000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31692000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32281000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31895000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32317000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
150000
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
90000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
144000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
77000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31842000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32371000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32039000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32394000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.19
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.19
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1200000
CY2020 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1800000
dorm Lease Effective Date
LeaseEffectiveDate
2018-01-01

Files In Submission

Name View Source Status
0001564590-21-051711-index-headers.html Edgar Link pending
0001564590-21-051711-index.html Edgar Link pending
0001564590-21-051711.txt Edgar Link pending
0001564590-21-051711-xbrl.zip Edgar Link pending
dorm-10q_20210925.htm Edgar Link pending
dorm-10q_20210925_htm.xml Edgar Link completed
dorm-20210925.xsd Edgar Link pending
dorm-20210925_cal.xml Edgar Link unprocessable
dorm-20210925_def.xml Edgar Link unprocessable
dorm-20210925_lab.xml Edgar Link unprocessable
dorm-20210925_pre.xml Edgar Link unprocessable
dorm-ex311_8.htm Edgar Link pending
dorm-ex312_7.htm Edgar Link pending
dorm-ex32_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g1hgqrhxrzv3000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending